Other Information
−Removed: Not applicable.
+Added: Form 8-K Item 1.01 Disclosure
+Added: On August 4, 2021, the Company entered into an amendment to the Credit Agreement with Citizens Bank, N.A.
+Added: (the “Credit Agreement Amendment”) to, among other things, extend the maturity date of the Company’s Revolving Credit Facility to August 3, 2022.
+Added: The foregoing description of the Credit Agreement Amendment is qualified in its entirety by reference to the text of the Credit Agreement Amendment, which is being filed herewith as Exhibit 10.1 and the terms of which are incorporated herein by reference.
+Added: Form 8-K Item 2.03 Disclosure
+Added: The information provided under “Form 8-K Item 1.01 Disclosure” is incorporated by reference into this Item 2.03.
+Added: Form 8-K Item 5.03 Disclosure
+Added: On July 31, 2021, the board of directors of the Company approved an amendment (the “Bylaw Amendment”) to the Amended and Restated Bylaws of the Company (the “Bylaws”), which became effective immediately.
+Added: The Bylaw Amendment added a new section 8.14 to the Bylaws which limits, to the fullest extent permitted by law, the forum for the resolution of any complaint under the Securities Act of 1933, as amended, to the federal district courts of the United States of America.
+Added: The foregoing summary of the Bylaw Amendment is qualified in its entirety by reference to the text of the Bylaw Amendment, which is being filed herewith as Exhibit 3.1 and the terms of which are incorporated herein by reference.
The following is a list of exhibits filed as part of this Quarterly Report on Form 10-Q.
1 unchanged sentence
For exhibits incorporated by reference, the location of the exhibit in the previous filing is indicated in parentheses.
+Added: Amendment to Bylaws effective as of July 31, 2021.
+Added: First Amendment to Credit Agreement, dated as of August 4, 2021, by and among Globus Medical, Inc., Globus Medical North America, Inc., and Citizens Banks, N.A.
Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
2 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
+Added: Globus Medical, Inc.
+Added: 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on June 4, 2021).
XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
9 unchanged sentences
GLOBUS MEDICAL, INC.
+Added: August 4, 2021
Chief Executive Officer
(Principal Executive Officer)
+Added: August 4, 2021
/s/ KEITH PFEIL
−Removed: Senior Vice President
Chief Financial Officer
Chief Accounting Officer
+Added: Senior Vice President
(Principal Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.